Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the survival benefit of adjuvant chemotherapy after curative resection with D2 or
greater lymph node dissection in T3-4 gastric cancer patients.